Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Gross Margin (2018 - 2025)

Abvc Biopharma (ABVC) has disclosed Gross Margin for 9 consecutive years, with 19844.86% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 1994486.0% year-over-year to 19844.86%, compared with a TTM value of 312.5% through Dec 2025, up 21265.0%, and an annual FY2025 reading of 100.0%, up 15.0% over the prior year.
  • Gross Margin was 19844.86% for Q4 2025 at Abvc Biopharma, down from 100.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 107.41% in Q4 2021 and bottomed at 19844.86% in Q4 2025.
  • Average Gross Margin over 5 years is 1541.29%, with a median of 92.61% recorded in 2022.
  • The sharpest move saw Gross Margin skyrocketed 642984bps in 2024, then tumbled -1994486bps in 2025.
  • Year by year, Gross Margin stood at 107.41% in 2021, then crashed by -49bps to 54.94% in 2022, then plummeted by -11622bps to 6329.84% in 2023, then surged by 102bps to 100.0% in 2024, then plummeted by -19945bps to 19844.86% in 2025.
  • Business Quant data shows Gross Margin for ABVC at 19844.86% in Q4 2025, 100.0% in Q4 2024, and 99.92% in Q3 2024.